506 related articles for article (PubMed ID: 25368290)
1. Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer.
Agarwal A; Daly KP; Butler-Bowen H; Saif MW
Anticancer Res; 2014 Nov; 34(11):6775-8. PubMed ID: 25368290
[TBL] [Abstract][Full Text] [Related]
2. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.
Van Cutsem E; Tabernero J; Lakomy R; Prenen H; Prausová J; Macarulla T; Ruff P; van Hazel GA; Moiseyenko V; Ferry D; McKendrick J; Polikoff J; Tellier A; Castan R; Allegra C
J Clin Oncol; 2012 Oct; 30(28):3499-506. PubMed ID: 22949147
[TBL] [Abstract][Full Text] [Related]
3. Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program.
Salgado Fernández M; Pérez Hoyos MT; Díaz de Corcuera I; Vidal Arbués A; García de la Torre M
Expert Opin Drug Saf; 2015 Aug; 14(8):1171-9. PubMed ID: 26076885
[TBL] [Abstract][Full Text] [Related]
4. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.
Ruff P; Ferry DR; Lakomỳ R; Prausová J; Van Hazel GA; Hoff PM; Cunningham D; Arnold D; Schmoll HJ; Moiseyenko VM; McKendrick JJ; Ten Tije AJ; Vishwanath RL; Bhargava P; Chevalier S; Macarulla T; Van Cutsem E
Eur J Cancer; 2015 Jan; 51(1):18-26. PubMed ID: 25466509
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain.
Feliu J; Díez de Corcuera I; Manzano JL; Valladares-Ayerbes M; Alcaide J; García García T; Vera R; Sastre J
Clin Transl Oncol; 2017 Apr; 19(4):498-507. PubMed ID: 27718155
[TBL] [Abstract][Full Text] [Related]
6. AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.
Pentheroudakis G; Kotoula V; Koliou GA; Karavasilis V; Samantas E; Aravantinos G; Kalogeropoulou L; Souglakos I; Kentepozidis N; Koumakis G; Sgouros J; Zarkavelis G; Efstratiou I; Laschos K; Petraki C; Tikas I; Poulios C; Voutsina A; Goudopoulou A; Bafaloukos D; Vrettou E; Kalogera-Fountzila A; Pectasides D; Fountzilas G
Clin Colorectal Cancer; 2018 Dec; 17(4):e631-e637. PubMed ID: 29980490
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of aflibercept in combination with fluorouracil, leucovorin and irinotecan in the treatment of Asian patients with metastatic colorectal cancer.
Chong DQ; Manalo M; Imperial M; Teo P; Yong G; Ng M; Tan IB; Choo SP; Chua C
Asia Pac J Clin Oncol; 2016 Sep; 12(3):275-83. PubMed ID: 27075236
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
9. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience.
Siperstein AE; Berber E; Ballem N; Parikh RT
Ann Surg; 2007 Oct; 246(4):559-65; discussion 565-7. PubMed ID: 17893492
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.
Tanis E; Nordlinger B; Mauer M; Sorbye H; van Coevorden F; Gruenberger T; Schlag PM; Punt CJ; Ledermann J; Ruers TJ
Eur J Cancer; 2014 Mar; 50(5):912-9. PubMed ID: 24411080
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.
Lambrechts D; Thienpont B; Thuillier V; Sagaert X; Moisse M; Peuteman G; Pericay C; Folprecht G; Zalcberg J; Zilocchi C; Margherini E; Chiron M; Van Cutsem E
Br J Cancer; 2015 Sep; 113(7):1027-34. PubMed ID: 26355232
[TBL] [Abstract][Full Text] [Related]
12. Aflibercept.
Ciombor KK; Berlin J; Chan E
Clin Cancer Res; 2013 Apr; 19(8):1920-5. PubMed ID: 23444216
[TBL] [Abstract][Full Text] [Related]
13. [Aflibercept (Zaltrap(®)) approved in metastatic colorectal cancer].
André T; Chibaudel B
Bull Cancer; 2013 Oct; 100(10):1023-5. PubMed ID: 24047539
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
15. [A case of laparoscopic radiofrequency ablation for liver metastatic tumor from colorectal carcinoma].
Nishigaki T; Mikami K; Murata K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2289-90. PubMed ID: 22202358
[TBL] [Abstract][Full Text] [Related]
16. Phase III aflibercept-chemotherapy combination trial shows benefit in previously treated metastatic colorectal cancer patients.
Oncology (Williston Park); 2011 Nov; 25(12):1213. PubMed ID: 22229217
[No Abstract] [Full Text] [Related]
17. Aflibercept. Metastatic colorectal cancer: at least as poorly tolerated as bevacizumab.
Prescrire Int; 2014 Sep; 23(152):205. PubMed ID: 25325116
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of addition of bevacizumab to oxaliplatin-based preoperative chemotherapy in colorectal cancer with liver metastasis- a single institution experience.
Cvetanovic A; Vrbic S; Filipovic S; Pejcic I; Milenkovic D; Milenkovic N; Zivkovic N
J BUON; 2013; 18(3):641-6. PubMed ID: 24065477
[TBL] [Abstract][Full Text] [Related]
19. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
20. High-dose FOLFIRI, surgery, and radiofrequency ablation for patients with unresectable liver metastases from colorectal cancer.
Hebbar M; Truant S; Desauw C; Sergent-Baudson G; Cattan S; Piessen G; Pruvot FR
Anticancer Res; 2013 Apr; 33(4):1603-7. PubMed ID: 23564804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
